Characterization of the alanine racemases from two mycobacteria.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  FEMS Microbiology Letters

• Publication date

  2001-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1574-6968.2001.TB10547.XPMID 11267762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of the alanine racemases from Pseudomonas aeruginosa PAO1.

  2000cited by this paper
• Characterization of the Alanine Racemases from Pseudomonas aeruginosa PAO1

  2000cited by this paper
• Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid.

  1998cited by this paper
• Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

  1998cited by this paper
• Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP synthase by isoniazid

  1998cited by this paper
• Mycolic acid biosynthesis: definition and targeting of the Claisen condensation step.

  1997cited by this paper
• Tuberculosis in the AIDS era

  1995cited by this paper
• Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant.

  1995cited by this paper
• Antimicrobial agent resistance in mycobacteria: molecular genetic insights

  1995cited by this paper
• The envelope of mycobacteria.

  1995cited by this paper
• Effect of HIV treatment on cognition, behavior, and emotion.

  1994cited by this paper
• Purification and characterization of eucaryotic alanine racemase acting as key enzyme in cyclosporin biosynthesis.

  1994cited by this paper
• Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin.

  1993cited by this paper
• Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

  1992cited by this paper
• The presence of free D-alanine, D-proline and D-serine in mice.

  1992cited by this paper
• The new tuberculosis.

  1992cited by this paper
• New method for generating deletions and gene replacements in Escherichia coli

  1989cited by this paper
• Thermostable alanine racemase from Bacillus stearothermophilus: molecular cloning of the gene, enzyme purification, and characterization.

  1986cited by this paper
• Biosynthetic alanine racemase of Salmonella typhimurium: purification and characterization of the enzyme encoded by the alr gene.

  1986cited by this paper
• Two alanine racemase genes in Salmonella typhimurium that differ in structure and function

  1983cited by this paper
• A simple method for displaying the hydropathic character of a protein.

  1982cited by this paper
• Suicide substrates for the alanine racemase of Escherichia coli B.

  1978cited by this paper
• Mechanism of d-Cycloserine Action: Alanine Racemase from Escherichia coli W

  1972cited by this paper
• A Note on the Kinetics of Enzyme Action.

  year unknowncited by this paper

• The Pyridoxal-5'-Phosphate-Dependent Enzymes of Mycobacterium tuberculosis.

  2026cites this paper
• Computational drug repurposing reveals potential alanine racemase inhibitors for combating drug-resistant tuberculosis

  2025cites this paper
• Cycloserine resistance among drug-resistant tuberculosis cases in Taiwan

  2025cites this paper
• l-Alanine Exporter AlaE Functions as One of the d-Alanine Exporters in Escherichia coli

  2023cites this paper
• Mycobacterium tuberculosis survival and biofilm formation studies: effect of d-amino acids, d-cycloserine and its components

  2022cites this paper
• Low-cost anti-mycobacterial drug discovery using engineered E. coli

  2022cites this paper
• The Short-chain Fatty Acid Propionic Acid Activates the Rcs Stress Response System Partially through Inhibition of d-Alanine Racemase

  2022cites this paper
• Evolution and properties of alanine racemase from Synechocystis sp. PCC6803.

  2021cites this paper
• Aptamer-Based Diagnostic Systems for the Rapid Screening of TB at the Point-of-Care

  2021cites this paper
• Low-cost drug discovery with engineered E. coli reveals an anti-mycobacterial activity of benazepril

  2021influential citation
• Cell Wall Anchoring of a Bacterial Chitosanase in Lactobacillus plantarum Using a Food-Grade Expression System and Two Versions of an LP × TG Anchor

  2020cites this paper
• Immunoscreening of the M. tuberculosis F15/LAM4/KZN secretome library against TB patients' sera identifies unique active- and latent-TB specific biomarkers.

  2019cites this paper
• Biochemical characterization and mutational analysis of alanine racemase from Clostridium perfringens.

  2019cites this paper
• β-Galactosidase from Lactobacillus helveticus DSM 20075: Biochemical Characterization and Recombinant Expression for Applications in Dairy Industry

  2019cites this paper
• Anti‐tuberculosis Agents

  2019cites this paper
• Identification of a new alanine racemase in Salmonella Enteritidis and its contribution to pathogenesis

  2018cites this paper
• Review on Mycobacterial Metabolic Pathways as Drug Targets

  2018cites this paper
• Cloning and characterization of MAP2191 gene, a mammalian cell entry antigen of Mycobacterium avium subspecies paratuberculosis

  2018cites this paper
• Enzymatic characterization and crystal structure of biosynthetic alanine racemase from Pseudomonas aeruginosa PAO1.

  2018cites this paper
• Localization and Regulation of the T1 Unimolecular Spanin

  2018influential citation
• Identification and elucidation of in vivo function of two alanine racemases from Pseudomonas putida KT2440

  2017cites this paper
• Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance.

  2017cites this paper
• Estudio bioquímico, genético y biotecnológico de la ruta catabólica responsable de la transformación de histamina en ácido imidazolacético en "Pseudomonas putida" U = Biochemical, genetic and biotechnological study of the catabolic pathway involved in the transformation of histamine into imidazoleac

  2017cites this paper
• Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine Resistance

  2017cites this paper
• Genetic mechanisms of D-cycloserine resistance.

  2016cites this paper
• Constitutive expression of a β-mannanase in Lactobacillus plantarum Submitted

  2016cites this paper
• Therapeutic Targets and Rational Drug Designing for Antitubercular Drugs

  2016cites this paper
• Identification of putative drug targets in Vancomycin-resistant Staphylococcus aureus (VRSA) using computer aided protein data analysis.

  2016cites this paper
• Secretion of d-alanine by Escherichia coli.

  2016cites this paper
• Mycobacterial Metabolic Pathways as Drug Targets: A Review

  2016influential citation
• Mechanistic and Evolutionary Insights from the Reciprocal Promiscuity of Two Pyridoxal Phosphate-dependent Enzymes

  2016cites this paper
• Mycobacterial Metabolic Pathways as Drug Targets: A Review

  2016cites this paper
• Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase

  2015cites this paper
• Membrane fusion during phage lysis

  2015influential citation
• Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015.

  2015cites this paper
• The structure of alanine racemase from Acinetobacter baumannii

  2014cites this paper
• Metabolomics analysis identifies d-Alanine-d-Alanine ligase as the primary lethal target of d-Cycloserine in mycobacteria.

  2014cites this paper
• l-Arabinose Isomerase and d-Xylose Isomerase from Lactobacillus reuteri: Characterization, Coexpression in the Food Grade Host Lactobacillus plantarum, and Application in the Conversion of d-Galactose and d-Glucose

  2014cites this paper
• Selected Therapeutic Targets of Tuberculosis: An Overview

  2014cites this paper
• DOCKING STUDIES FOR TUBERCULOSIS TAKING ALANINE RACEMASE AS A RECEPTOR AND A NOVEL PLANT SOURCE QUERCETIN AS A POTENTIAL DRUG SOURCE

  2014cites this paper
• Production and secretion of bacillus chitosanase in lactobacillus plantarum expression system

  2014cites this paper
• Molecular basis underlying Mycobacterium tuberculosis D-cycloserine resistance. Is there a role for ubiquinone and meraquinone metabolic pathways?

  2014cites this paper
• Characterization and preliminary mutation analysis of a thermostable alanine racemase from Thermoanaerobacter tengcongensis MB4

  2013influential citation
• Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones.

  2013influential citation
• Evaluation of the food grade expression systems NICE and pSIP for the production of 2,5-diketo-D-gluconic acid reductase from Corynebacterium glutamicum

  2013influential citation
• Alanine racemase mutants of Mycobacterium tuberculosis require D-alanine for growth and are defective for survival in macrophages and mice.

  2012cites this paper
• Preparation of D-cycloserine and 13C-labeled D-cycloserine

  2012cites this paper
• 9 Antitubercular Drugs Development : Recent Advances in Selected Therapeutic Targets and Rational Drug Design

  2012cites this paper
• Development of a high-throughput screening method for racemase activity and its application to the identification of alanine racemase variants with activity towards l-arginine

  2012cites this paper
• Enzyme promiscuity and the origins of cellular innovations : a dissertation presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Biochemistry at Massey University, Albany, New Zealand

  2012influential citation
• Antitubercular Drugs Development: Recent Advances in Selected Therapeutic Targets and Rational Drug Design

  2011cites this paper
• New Classes of Alanine Racemase Inhibitors Identified by High-Throughput Screening Show Antimicrobial Activity against Mycobacterium tuberculosis

  2011cites this paper
• A food-grade system for inducible gene expression in Lactobacillus plantarum using an alanine racemase-encoding selection marker.

  2011cites this paper
• Alanine Racemase Mutants of Burkholderia pseudomallei and Burkholderia mallei and Use of Alanine Racemase as a Non-Antibiotic-Based Selectable Marker

  2011cites this paper
• Correlation between catalytic activity and monomer-dimer equilibrium of bacterial alanine racemases.

  2011cites this paper
• Identification of an L-alanine export system in Escherichia coli and isolation and characterization of export-deficient mutants.

  2011cites this paper
• Biochemical Characteristics of a Bacteria (Bacillus pseudomycoides) Alanine Racemase Expressed in Escherichia coli

  2010cites this paper
• Upregulation of MetC Is Essential for d-Alanine-Independent Growth of an alr/dadX-Deficient Escherichia coli Strain

  2010cites this paper
• The role of the efflux mechanisms in multidrug resistance in Mycobacterium tuberculosis

  2010cites this paper
• Protein interaction network analysis--approach for potential drug target identification in Mycobacterium tuberculosis.

  2010cites this paper
• Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis

  2010cites this paper
• Mycobacterium tuberculosis: drug resistance and future perspectives.

  2009cites this paper
• A PHARMACOKINETICS AND PHARMACODYNAMICS (PK/PD) GUIDED APPROACH TO LEAD OPTIMIZATION OF NITROFURANYLAMIDE ANTI-TUBERCULOSIS AGENTS

  2009cites this paper
• Biochemical and structural characterization of alanine racemase from Bacillus anthracis (Ames)

  2009cites this paper
• Cytoplasmic steps of peptidoglycan biosynthesis.

  2008cites this paper
• Biopharmaceutics, pharmacokinetics and pharmacodynamics of antituberculosis drugs.

  2008cites this paper
• Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy

  2008cites this paper
• Medications for Extensively Drug-Resistant Tuberculosis: Back to the Future?

  2008cites this paper
• Gene cloning and characterization of a second alanine racemase from Bacillus subtilis encoded by yncD.

  2008influential citation
• Residues Asp164 and Glu165 at the substrate entryway function potently in substrate orientation of alanine racemase from E. coli: Enzymatic characterization with crystal structure analysis

  2008influential citation
• Cloning and analysis of two alanine racemase genes fromBacillus licheniformis

  2008influential citation
• New tuberculosis drugs in development.

  2007cites this paper
• Alanine racemase from Helicobacter pylori NCTC 11637: purification, characterization and gene cloning.

  2007cites this paper
• Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase.

  2007cites this paper
• Relationship between Dimerization and Enzyme Activity in Bacterial Alanine Racemases

  2007cites this paper
• Metabolic Pathway Analysis of S. Pneumoniae: an in silico Approach towards Drug-Design

  2007cites this paper
• The Alanine Racemase of Mycobacterium smegmatis Is Essential for Growth in the Absence of d-Alanine

  2007cites this paper
• Purification and preliminary crystallization of alanine racemase from Streptococcus pneumoniae

  2007cites this paper
• Alanine, Aspartate, and Asparagine Metabolism in Microorganisms

  2006cites this paper
• Expression of alr gene from Corynebacterium glutamicum ATCC 13032 in Escherichia coli and molecular characterization of the recombinant alanine racemase.

  2006cites this paper
• In Vivo Bactofection: Listeria Can Function as a DNA-Cancer Vaccine

  2006cites this paper
• United States Patent: D-ALANINE RACEMASE MUTANTS OF MYCOBACTERIA AND USES THEREFORE

  2005cites this paper
• Genetic and Biochemical Characterization of Peptidoglycan Synthesis in Chlamydia

  2005cites this paper
• D-ALANINE RACEMASE MUTANTS OF MYCOBACTERIA AND USES THEREFORE: U.S. Patent No. US 6,929,799 B2

  2005cites this paper
• Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis

  2005cites this paper
• The magic bullets and tuberculosis drug targets.

  2005cites this paper
• Cloning of alanine racemase genes from Pseudomonas fluorescens strains and oligomerization states of gene products expressed in Escherichia coli.

  2005cites this paper
• The 1.9 A crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site.

  2005cites this paper
• Directed evolution of bacterial alanine racemases with higher expression level.

  2005cites this paper
• Self-protection Mechanism in d-Cycloserine-producing Streptomyces lavendulae

  2004cites this paper
• Listeria monocytogenes-Based Antibiotic Resistance Gene-Free Antigen Delivery System Applicable to Other Bacterial Vectors and DNA Vaccines

  2004cites this paper
• Identification and validation of novel drug targets in tuberculosis.

  2004cites this paper
• Mouse brain serine racemase catalyzes specific elimination of L‐serine to pyruvate

  2003cites this paper
• Improvement in thermostability and psychrophilicity of psychrophilic alanine racemase by site-directed mutagenesis

  2003cites this paper
• Subunit interaction of monomeric alanine racemases from four Shigella species in catalytic reaction.

  2003cites this paper
• Roles of Mycobacterium smegmatisd-Alanine:d-Alanine Ligase and d-Alanine Racemase in the Mechanisms of Action of and Resistance to the Peptidoglycan Inhibitor d-Cycloserine

  2003cites this paper
• N(2)-substituted D,L-cycloserine derivatives: synthesis and evaluation as alanine racemase inhibitors.

  2003cites this paper
• Mycobacterium smegmatis d-Alanine Racemase Mutants Are Not Dependent on d-Alanine for Growth

  2002cites this paper
• The alanine racemase gene alr is an alternative to antibiotic resistance genes in cloning systems for industrial Corynebacterium glutamicum strains.

  2002cites this paper
• Mutant Analysis Shows that Alanine Racemases from Pseudomonas aeruginosa and Escherichia coli Are Dimeric

  2002cites this paper